Differential escape mechanisms in cetuximab-resistant head and neck cancer cells
Year: 2019
Type: article
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Eli Lilly and Company, AstraZeneca
OpenAlex ID: W2962320367
